Abstract
With the ageing population, musculoskeletal conditions are becoming more inherent. Delayed union is defined as a slower than normal fracture healing response, with no healing after 4 to 6 months; however, the union is anticipated given sufficient time. In the context of delayed/non-union, fragility fractures in osteoporotic populations carry significant patient morbidity and socioeconomic costs. Multiple mechanisms hinder fracture healing in osteoporotic patients, imbalanced bone remodelling leads to impaired bone microarchitecture due to reduced osteoblast number and activity and as such, callus formation is diminished. Since stem cells can self-renew and differentiate into various tissue lineages, they are becoming very popular in tissue regeneration in musculoskeletal conditions. In this review, we discuss the role of stem cells in physiological fracture healing and their potential therapeutic use following a fracture. We explore the potential of stem cells, the release of chemokines and cytokines to reduce fracture risk in osteoporosis.
Keywords: Stem cells, fracture, osteoporosis, bone, healing, regeneration.
Current Stem Cell Research & Therapy
Title:Stem Cell Interventions for Bone Healing: Fractures and Osteoporosis
Volume: 13 Issue: 5
Author(s): Anita Sanghani-Kerai*, Dara McCreary, Henry Lancashire, Liza Osagie, Melanie Coathup and Gordon Blunn
Affiliation:
- Institute of Orthopaedics and Musculoskeletal Science, Division of Surgery and Interventional Sciences, University College London, Stanmore, London, HA7 4LP,United Kingdom
Keywords: Stem cells, fracture, osteoporosis, bone, healing, regeneration.
Abstract: With the ageing population, musculoskeletal conditions are becoming more inherent. Delayed union is defined as a slower than normal fracture healing response, with no healing after 4 to 6 months; however, the union is anticipated given sufficient time. In the context of delayed/non-union, fragility fractures in osteoporotic populations carry significant patient morbidity and socioeconomic costs. Multiple mechanisms hinder fracture healing in osteoporotic patients, imbalanced bone remodelling leads to impaired bone microarchitecture due to reduced osteoblast number and activity and as such, callus formation is diminished. Since stem cells can self-renew and differentiate into various tissue lineages, they are becoming very popular in tissue regeneration in musculoskeletal conditions. In this review, we discuss the role of stem cells in physiological fracture healing and their potential therapeutic use following a fracture. We explore the potential of stem cells, the release of chemokines and cytokines to reduce fracture risk in osteoporosis.
Export Options
About this article
Cite this article as:
Sanghani-Kerai Anita *, McCreary Dara , Lancashire Henry , Osagie Liza , Coathup Melanie and Blunn Gordon , Stem Cell Interventions for Bone Healing: Fractures and Osteoporosis, Current Stem Cell Research & Therapy 2018; 13 (5) . https://dx.doi.org/10.2174/1574888X13666180410160511
DOI https://dx.doi.org/10.2174/1574888X13666180410160511 |
Print ISSN 1574-888X |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3946 |
![Wayfinder Image](/images/wayfinder.jpg)
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Emerging Pharmacological Treatments to Prevent Abdominal Aortic Aneurysm Growth and Rupture
Current Pharmaceutical Design Potential of Nanotechnology-based Formulations in Combating Pulmonary Infectious Diseases: A Current Scenario
Current Pharmaceutical Design Leber's Hereditary Optic Neuropathy: Novel Views and Persisting Challenges
CNS & Neurological Disorders - Drug Targets Imaging Stem Cell Therapy for the Treatment of Peripheral Arterial Disease
Current Vascular Pharmacology Calixarene: A Versatile Material for Drug Design and Applications
Current Pharmaceutical Design Liraglutide Exerts Potential Anti-inflammatory Effect in Type 1 Diabetes by Inhibiting IFN-γ Production <I>via</I> Suppressing JAK-STAT Pathway
Endocrine, Metabolic & Immune Disorders - Drug Targets Emerging Targets to Relieve Fat Stress-Induced Liver Diseases: UDCA, Tocotrienol, ω-3 PUFAs, and IgY Targeted NPC1L1 Cholesterol Transporter
Current Pharmaceutical Design Exploring Polypharmacology in Drug Discovery and Repurposing Using the CANDO Platform
Current Pharmaceutical Design Heme Oxygenase-1/CO as Protective Mediators in Cigarette Smoke- Induced Lung Cell Injury and Chronic Obstructive Pulmonary Disease
Current Pharmaceutical Biotechnology Current Overview on the Potency of Natural Products for Modulating Myeloid-derived Suppressor Cells Dependent Cold Tumors
Current Medicinal Chemistry Potential Application of Non-flavonoid Phenolics in Diabetes: Antiinflammatory Effects
Current Medicinal Chemistry A QSAR Study on Some Series of Anti-Hepatitis C Virus (HCV) Agents
Letters in Drug Design & Discovery The Rationale for Comparative Studies of Accelerated Atherosclerosis in Rheumatic Diseases
Current Vascular Pharmacology IFN-γ and TNF-α Gene Polymorphisms in Multiple Sclerosis Patients in Northwest Iran
Endocrine, Metabolic & Immune Disorders - Drug Targets <i>In-vitro</i> Safety Assessment of Ultrasmall Gold Nanoparticles for Preclinical Drug Delivery Applications
Drug Delivery Letters Genetic and Molecular Determinants of Atherosclerotic Plaque Instability
Current Vascular Pharmacology Genomic and Epigenomic Instability, Fragile Sites, Schizophrenia and Autism
Current Genomics Potential Anti-Catabolic and Anabolic Properties of Strontium Ranelate
Current Molecular Pharmacology T Cell Homeostasis in Centenarians: From the Thymus to the Periphery
Current Pharmaceutical Design Adenosine and ATP Receptors in the Brain
Current Topics in Medicinal Chemistry